|
iC9.GD2.CAR.IL-15 T Infusion Clinical Trials
1 actively recruiting trial across 1 location
Chapel Hill, North Carolina1 trial
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
Lineberger Comprehensive Cancer Center
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.